(EMAILWIRE.COM, January 17, 2019 ) The non-ionizing breast imaging technologies segment is classified into five subsegments, namely, breast MRI, breast ultrasound, automated whole breast ultrasound (AWBU), breast thermography, and optical imaging. The automated whole-breast ultrasound (AWBU) segment is expected to grow at the highest CAGR in the next five years, owing to benefits such as high reproducibility, high resolution power with 3D capability, lower false positives, and faster imaging.

This report studies the breast imaging technologies market over the forecast period of 2016 to 2021. The market is expected to reach USD 4.14 Billion by 2021, at a CAGR of 8.5% from 2016 to 2021. A number of factors such as rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues are driving the growth of the global breast imaging market. However, high installation cost of breast imaging systems, side effects of radiation exposure, and errors in breast cancer screening and diagnosis are some of the major factors restraining the growth of this market. In addition, stringent regulatory approval procedures and unfavorable reimbursement scenario in developing countries are expected to further restrain the growth of this market in the coming years.

Sample Report - https://www.marketsandmarkets.com/requestsampleNew.asp?id=897

The breast imaging market is segmented into four major regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is estimated to dominate the global breast imaging market, majorly due to the rising incidence of breast cancer, favorable reimbursement scenario, ongoing technological advancements by market players, implementation of new breast density notification law in the U.S., rapid growth in geriatric population, and growing demand for the use of low levels or negligible radiation doses in the region. On the other hand, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. The high growth in this market can majorly be attributed to the rising patient population, increasing healthcare expenditure, higher government spending on breast cancer research studies, and implementation of several programs focused on creating awareness about the early detection of breast cancer.

Download Free PDF - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897

Key Players
Hologic, Inc. (U.S.), GE Healthcare (U.K.), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), Fujifilm Holdings Corporation (Japan), Gamma Medica, Inc. (U.S.), Toshiba Corporation (Japan), Sonocine, Inc. (U.S.), Aurora Imaging Technology, Inc. (U.S.), and Dilon Technologies, Inc. (U.S.) are some of the key players operating in the global breast imaging market.